-
disease targets. Our focus includes kidney, immune, and other hard-to-treat diseases. As a subsidiary of Otsuka Pharmaceutical Co., Ltd. of Japan, Visterra benefits from the agility of an innovative
Enter an email to receive alerts for parallel-processing
positions in computer-science